Business
Dr Reddy's Q1 FY27 net profit crashes 69% to ₹4,435 crore on semaglutide hit
Dr Reddy's posted one of its worst quarterly performances in years — a 69% profit collapse driven by a semaglutide API impurity crisis, a ₹240 crore provision, and a brutal 35% drop in North America…